Cortexyme, Inc. Business Finance Contracts & Agreements

20 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Quince Therapeutics, Inc. Registration Rights Agreement with Investors (June 12, 2025)
Registration Rights Agreements
Cortexyme, Inc.
Biotechnology
2025
Securities Purchase Agreement between Quince Therapeutics, Inc. and Investors (June 12, 2025)
Purchase Agreements
Cortexyme, Inc.
Biotechnology
NY
2025
Quince Therapeutics, Inc. Warrant to Purchase Common Stock or Pre-Funded Warrants (2025)
Warrant Agreements
Cortexyme, Inc.
Biotechnology
NY
2025
Quince Therapeutics, Inc. Pre-Funded Warrant to Purchase Common Stock Agreement
Warrant Agreements
Cortexyme, Inc.
Biotechnology
NY
2025
Description of Quince Therapeutics, Inc. Securities Registered Under Section 12 of the Securities Exchange Act of 1934
Equity Distribution Agreements
Cortexyme, Inc.
Biotechnology
2025
Autonomous First Demand Guarantee Agreement between Quince Therapeutics, Inc. and European Investment Bank
Guaranty Agreements
Cortexyme, Inc.
Biotechnology
DE
2024
Accession, Amendment and Restatement Agreement to Finance Contract between European Investment Bank and Erydel S.p.A. (with Guarantors)
Investment Agreements
Cortexyme, Inc.
Biotechnology
CA
2024
Stock Purchase Agreement among Quince Therapeutics, Inc., EryDel Italy, Inc., EryDel S.p.A., Shareholders, and Shareholder Representative Services LLC
Purchase Agreements
Cortexyme, Inc.
Biotechnology
DE
2023
Asset Purchase Agreement between Quince Therapeutics, Inc. and Lighthouse Pharmaceuticals, Inc. dated January 27, 2023
Purchase Agreements
Cortexyme, Inc.
Biotechnology
DE
2023
Rights Agreement between Quince Therapeutics, Inc. and American Stock Transfer & Trust Company, LLC (April 5, 2023)
Purchase Agreements
Cortexyme, Inc.
Biotechnology
DE
2023
Open Market Sale Agreement between Cortexyme, Inc. and Jefferies LLC (December 23, 2021)
Equity Distribution Agreements
Cortexyme, Inc.
Biotechnology
NY
2021
Description of Cortexyme, Inc. Securities Registered Under Section 12 of the Exchange Act
Registration Rights Agreements
Cortexyme, Inc.
Biotechnology
2021
Description of Cortexyme, Inc. Securities Registered Under Section 12 of the Exchange Act
Registration Rights Agreements
Cortexyme, Inc.
Biotechnology
2020
Stock Purchase Agreement between Cortexyme, Inc. and Purchaser (February 5, 2020)
Stock Agreements
Cortexyme, Inc.
Biotechnology
2020
Cortexyme, Inc. 2019 Employee Stock Purchase Plan
Equity Distribution Agreements
Cortexyme, Inc.
Biotechnology
2019
Cortexyme, Inc. 2019 Equity Incentive Plan
Equity Distribution Agreements
Cortexyme, Inc.
Biotechnology
DE
2019
Cortexyme, Inc. Common Stock Certificate Issued by American Stock Transfer & Trust Company, LLC
Stock Agreements
Cortexyme, Inc.
Biotechnology
2019
Underwriting Agreement between Cortexyme, Inc. and Merrill Lynch, Pierce, Fenner & Smith Incorporated and Credit Suisse Securities (USA) LLC, Dated May [•], 2019
Underwriting Agreements
Cortexyme, Inc.
Biotechnology
NY
2019
Cortexyme, Inc. 2014 Stock Plan
Stock Agreements
Cortexyme, Inc.
Biotechnology
CA
2019
Amended and Restated Investors' Rights Agreement by and among Cortexyme, Inc. and Certain Investors and Key Holders (May 23, 2018)
Investor Rights Agreements
Cortexyme, Inc.
Biotechnology
CA
2019